| Current Price | $23.43 | Mkt Cap | $1.9B |
|---|---|---|---|
| Open | $23.01 | P/E Ratio | -13.00 |
| Prev. Close | $23.43 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $22.67 - $23.58 | Volume | 632,890 |
| 52-Wk Range | $13.92 - $28.18 | Avg. Daily Vol. | 595,985 |
Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.
| Current Price | $23.43 | Mkt Cap | $1.9B |
|---|---|---|---|
| Open | $23.01 | P/E Ratio | -13.00 |
| Prev. Close | $23.43 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $22.67 - $23.58 | Volume | 632,890 |
| 52-Wk Range | $13.92 - $28.18 | Avg. Daily Vol. | 595,985 |
The best Bull and Bear pitches based on recency and number of recommendations.
The company's genetic testing has wide applications, particularly for breast cancer, and is is seeing steady revenue growth.
Read the most recent pitches from players about MYGN.
Recs
TMFjimhalley
(< 20)
Submitted: 8/25/2022 2:50:04 PM :
Start Price:
$24.71
NASDAQ:MYGN Score:
-8.31
The company's genetic testing has wide applications, particularly for breast cancer, and is is seeing steady revenue growth.
Recs
Stoic
(87.39)
Submitted: 3/5/2021 11:59:15 AM :
Start Price:
$27.22
NASDAQ:MYGN Score:
+28.09
Overvalued
Recs
Capitalism
(71.89)
Submitted: 11/18/2019 1:40:42 PM :
Start Price:
$24.94
NASDAQ:MYGN Score:
-43.53
Akram's Razor long pick (pare trade with NVTA short)
Find the members with the highest scoring picks in MYGN.
Afropuffashion (22.15) Score: +530.35
The Score Leader is the player with the highest score across all their picks in MYGN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Afropuffashion | 22.15 | 2/27/2009 |
|
1Y | $40.00 | -41.60% | +488.75% | +530.35 | 1 Comment | |
| anticitradeshort | 27.13 | 4/20/2009 |
|
NS | $44.11 | -47.04% | +405.86% | +452.90 | 0 Comment | |
| mcornice | 88.86 | 4/30/2009 |
|
3M | $39.68 | -41.13% | +388.49% | +429.62 | 1 Comment | |
| wofaintagain | < 20 | 10/15/2009 |
|
3M | $26.30 | -11.18% | +292.42% | +303.60 | 0 Comment | |
| pinoyrags2riches | 67.89 | 10/14/2009 |
|
NS | $25.59 | -8.71% | +294.59% | +303.31 | 0 Comment | |
| dangerfall2010 | < 20 | 2/26/2010 |
|
5Y | $22.52 | +3.73% | +286.86% | +283.13 | 2 Comments | |
| redbearish | < 20 | 2/23/2010 |
|
3M | $22.38 | +4.38% | +286.30% | +281.92 | 2 Comments | |
| competitorbetter | < 20 | 5/25/2010 |
|
5Y | $18.20 | +28.35% | +304.20% | +275.85 | 1 Comment | |
| aslongas | < 20 | 5/25/2010 |
|
5Y | $18.15 | +28.74% | +303.55% | +274.81 | 1 Comment | |
| francygucci | < 20 | 3/10/2010 |
|
1Y | $23.09 | +1.17% | +272.50% | +271.34 | 2 Comments |
See what the Wall Street professionals think, according to their public statements and filings.
